BlueLinx Holdings Inc. — Form 10-Q Summary
Period discrepancy: The request identifies “2020 Q3,” but the supplied filing is for the quarter ended October 2, 2021, filed November 2, 2021. Comparisons below are against the quarter ended September 26, 2020; year-to-date figures cover nine months.
Business context and reporting period
BlueLinx is a U.S. wholesale distributor of residential and commercial building products, selling structural and specialty products through warehouse, reload, and direct channels. The company reported that elevated construction demand and supply constraints supported specialty-product pricing, while commodity wood-price volatility materially affected structural-product results.
Financial performance and liquidity
| Metric | Q3 2021 | Q3 2020 | Nine months 2021 | Nine months 2020 |
|---|---|---|---|---|
| Net sales | $970.8 million | $871.1 million | $3,304.2 million | $2,231.9 million |
| Gross profit / margin | $153.3 million / 15.8% | $159.5 million / 18.3% | $584.9 million / 17.7% | $353.5 million / 15.8% |
| Operating income | $71.0 million | $81.5 million | $327.8 million | $111.9 million |
| Net income | $47.2 million | $55.1 million | $222.5 million | $61.0 million |
| Diluted EPS | $4.74 | $5.72 | $22.91 | $6.48 |
| Operating cash flow | Not separately reported | Not separately reported | $126.9 million | $74.4 million |
At October 2, 2021, cash was $0.2 million, receivables $345.0 million, inventory $436.4 million, and current liabilities $263.3 million. Revolver borrowings were $223.1 million, with reported excess availability of $351.9 million; the company was in covenant compliance. It had repaid its $43.2 million term loan in April. Finance lease liabilities totaled $276.9 million, including $243.2 million related to real estate. Long-term debt, net of current maturities, was $490.9 million, including finance lease obligations.
Material changes versus comparable periods
- Third-quarter sales increased about 11%, but net income declined about 14%. Gross margin fell 2.5 percentage points, primarily due to falling commodity wood prices and the sale of higher-cost structural inventory.
- Specialty sales rose to $641.0 million and specialty gross margin improved to 23.0% from 17.4%. Structural sales fell to $329.8 million, and structural gross margin dropped to 1.7% from 19.6%.
- For the first nine months, sales increased about 48% and net income rose to $222.5 million, reflecting strong earlier-year commodity price inflation and specialty pricing gains.
- Operating cash flow increased year over year, while operating working capital rose to $571.2 million from $470.7 million at fiscal year-end, mainly due to higher receivables and inventory amid inflation.
Outlook, commentary, risks, and unusual items
- Management cited housing and repair-and-remodel demand as supportive, but noted supply constraints, commodity-price movements, seasonality, and uncertainty from COVID-19 variants. It did not provide specific earnings or sales guidance.
- Management intended to invest up to $10 million in fleet and facilities in Q4 2021. A board-approved $25 million stock repurchase program had not been used for program repurchases as of the filing; employee tax-withholding share purchases are separate.
- On October 25, after quarter-end, the company issued $300 million of 6.0% senior secured notes due 2029 at 98.625% of face value. Most net proceeds were used to repay revolver borrowings, and the revolver commitment was reduced from $600 million to $350 million.
- A $16.7 million lower-of-cost-or-net-realizable-value reserve related to structural inventory was released in Q3 as the affected inventory was sold; the filing says the reserve had no net effect on nine-month results.
- Key risks include commodity price and inventory exposure, housing-market cyclicality, supply constraints, working-capital needs, variable-rate debt, leverage and lease commitments, COVID-19 uncertainty, and labor, legal, and environmental matters. Management reported no material change to previously disclosed risk factors; routine proceedings were not expected to have a material adverse effect.
Important facts for investors to verify
- Confirm the intended reporting period: the supplied filing is 2021 Q3, not 2020 Q3.
- Review the subsequent notes issuance and revolver reduction, including the resulting borrowing balance and interest costs after October 2.
- Assess whether specialty pricing and margins can persist and whether structural margins recover as commodity prices stabilize.
- Monitor inventory, receivables, working-capital requirements, and available revolver capacity.
- Review the reserve release’s effect on Q3 structural results and distinguish it from underlying performance.